# Tenaya Therapeutics, Inc.: filings

TNYA · Nasdaq · CIK 1858848 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tnya.md) · [Financials](/companies/tnya/financials.md) · [Filings](/companies/tnya/filings.md) · [Insiders](/companies/tnya/insiders.md)

## Reports and events: 94 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 124, 8-K 53, 144 26, 3 20, 10-Q 16, SC 13G 10, SC 13G/A 10, 424B5 8, S-8 8, CORRESP 7, UPLOAD 7, DEF 14A 6, DEFA14A 6, SCHEDULE 13D/A 6, 10-K 5, ARS 4, SC 13D/A 4, EFFECT 3, SCHEDULE 13G 3, SCHEDULE 13G/A 3, PRE 14A 2, S-3 2, SC 13D 2, SEC STAFF LETTER 2, 424B3 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1/A 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:47 ET | [DEF 14A](/filings/0001193125-26-430591.md) | Proxy statement, period 2026-12-09 | 0001193125-26-430591 |
| 2026-08-05 | 20:15 ET | [10-Q](/filings/0001193125-26-335140.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335140 |
| 2026-08-05 | 20:10 ET | [8-K](/filings/0001193125-26-335098.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335098 |
| 2026-07-02 | 21:00 ET | [8-K](/filings/0001193125-26-294879.md) | 1.02 Termination of a material agreement | 0001193125-26-294879 |
| 2026-06-29 | 13:00 ET | [8-K](/filings/0001193125-26-286957.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-286957 |
| 2026-05-29 | 21:04 ET | [8-K](/filings/0001193125-26-248680.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-248680 |
| 2026-05-06 | 20:24 ET | [10-Q](/filings/0001193125-26-209084.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209084 |
| 2026-05-06 | 20:11 ET | [8-K](/filings/0001193125-26-208975.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208975 |
| 2026-04-16 | 13:00 ET | [DEF 14A](/filings/0001193125-26-158079.md) | Proxy statement, period 2026-05-27 | 0001193125-26-158079 |
| 2026-03-11 | 20:28 ET | [10-K](/filings/0001193125-26-102252.md) | Annual report, period 2025-12-31 | 0001193125-26-102252 |
| 2026-03-11 | 20:14 ET | [8-K](/filings/0001193125-26-102170.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-102170 |
| 2026-03-05 | 13:35 ET | [8-K](/filings/0001193125-26-092654.md) | 1.01 Entry into a material agreement | 0001193125-26-092654 |
| 2026-02-26 | 21:29 ET | [SCHEDULE 13D/A](/filings/0001193125-26-076892.md) | Ownership report, active investor, amended | 0001193125-26-076892 |
| 2026-02-12 | 23:52 ET | [SCHEDULE 13D/A](/filings/0001193125-26-049218.md) | Ownership report, active investor, amended | 0001193125-26-049218 |
| 2026-01-30 | 22:06 ET | [8-K](/filings/0001193125-26-032017.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-032017 |
| 2026-01-02 | 22:10 ET | [8-K](/filings/0001193125-26-001065.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-001065 |
| 2025-12-17 | 21:16 ET | [SCHEDULE 13D/A](/filings/0001193125-25-322770.md) | Ownership report, active investor, amended | 0001193125-25-322770 |
| 2025-12-12 | 21:30 ET | [8-K](/filings/0001193125-25-317642.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-317642 |
| 2025-12-11 | 21:11 ET | [8-K](/filings/0001193125-25-315951.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-315951 |
| 2025-11-10 | 12:12 ET | [10-Q](/filings/0001193125-25-273239.md) | Quarterly report, period 2025-09-30 | 0001193125-25-273239 |
| 2025-11-10 | 12:07 ET | [8-K](/filings/0001193125-25-273230.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273230 |
| 2025-11-07 | 21:24 ET | [8-K](/filings/0001193125-25-272423.md) | 8.01 Other events | 0001193125-25-272423 |
| 2025-08-06 | 20:50 ET | [10-Q](/filings/0000950170-25-104182.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104182 |
| 2025-08-06 | 20:41 ET | [8-K](/filings/0000950170-25-104164.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104164 |
| 2025-05-30 | 20:32 ET | [8-K](/filings/0000950170-25-079773.md) | 5.07 Shareholder vote results | 0000950170-25-079773 |
| 2025-05-14 | 20:18 ET | [SCHEDULE 13D/A](/filings/0000950170-25-071441.md) | Ownership report, active investor, amended | 0000950170-25-071441 |
| 2025-05-07 | 20:27 ET | [10-Q](/filings/0000950170-25-065741.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065741 |
| 2025-05-07 | 20:18 ET | [8-K](/filings/0000950170-25-065703.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065703 |
| 2025-04-18 | 21:07 ET | [8-K](/filings/0000950170-25-055927.md) | 3.01 Delisting notice | 0000950170-25-055927 |
| 2025-04-17 | 20:05 ET | [DEF 14A](/filings/0001193125-25-084313.md) | Proxy statement, period 2025-05-28 | 0001193125-25-084313 |
| 2025-03-28 | 20:08 ET | [8-K](/filings/0001193125-25-067071.md) | 2.05 Exit or disposal costs | 0001193125-25-067071 |
| 2025-03-10 | 20:19 ET | [10-K](/filings/0000950170-25-036329.md) | Annual report, period 2024-12-31 | 0000950170-25-036329 |
| 2025-03-10 | 20:13 ET | [8-K](/filings/0000950170-25-036296.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036296 |
| 2025-03-07 | 01:22 ET | [SCHEDULE 13D/A](/filings/0000919574-25-001872.md) | Ownership report, active investor, amended | 0000919574-25-001872 |
| 2025-03-07 | 00:50 ET | [SCHEDULE 13D/A](/filings/0000950170-25-035821.md) | Ownership report, active investor, amended | 0000950170-25-035821 |
| 2025-03-04 | 21:28 ET | [8-K](/filings/0001193125-25-045628.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-045628 |
| 2025-02-07 | 21:41 ET | [8-K](/filings/0000950170-25-016378.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-016378 |
| 2025-01-28 | 22:12 ET | [8-K](/filings/0000950170-25-009946.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-009946 |
| 2024-12-17 | 12:58 ET | [8-K](/filings/0001193125-24-280112.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-280112 |
| 2024-12-17 | 12:24 ET | [8-K](/filings/0001193125-24-280092.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-280092 |
| 2024-11-06 | 21:20 ET | [10-Q](/filings/0000950170-24-122359.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122359 |
| 2024-11-06 | 21:16 ET | [8-K](/filings/0000950170-24-122342.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122342 |
| 2024-09-16 | 20:05 ET | [8-K](/filings/0000950170-24-106817.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-106817 |
| 2024-08-08 | 20:24 ET | [10-Q](/filings/0000950170-24-094059.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094059 |
| 2024-08-08 | 20:14 ET | [8-K](/filings/0000950170-24-093991.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-093991 |
| 2024-07-25 | 20:02 ET | [8-K](/filings/0001193125-24-184817.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-184817 |
| 2024-06-27 | 21:10 ET | [8-K](/filings/0000950170-24-078585.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-078585 |
| 2024-05-31 | 20:13 ET | [8-K](/filings/0000950170-24-067318.md) | 5.07 Shareholder vote results | 0000950170-24-067318 |
| 2024-05-14 | 20:15 ET | [10-Q](/filings/0000950170-24-059576.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059576 |
| 2024-05-14 | 20:09 ET | [8-K](/filings/0000950170-24-059539.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-24-059539 |

Page 1 of 2. [Older](/companies/tnya/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.